Invention Grant
- Patent Title: Oral formulations of metronidazole and methods of treating an infection using same
-
Application No.: US16959536Application Date: 2019-01-16
-
Publication No.: US11541035B2Publication Date: 2023-01-03
- Inventor: Bernard J. Guarino, Jr. , Jamie L. Doran , Zorana Radovic , Kevin Sullivan
- Applicant: Appili Therapeutics Inc.
- Applicant Address: CA Halifax
- Assignee: Appili Therapeutics Inc.
- Current Assignee: Appili Therapeutics Inc.
- Current Assignee Address: CA Halifax
- Agency: Biospark Intellectual Property Law
- International Application: PCT/CA2019/050053 WO 20190116
- International Announcement: WO2019/140516 WO 20190725
- Main IPC: A61K31/4164
- IPC: A61K31/4164 ; A61K47/02 ; A61K9/00 ; A61K47/26 ; A61K47/46 ; A61P31/04 ; A61K47/14 ; A61K47/38
Abstract:
The present disclosure provides oral pharmaceutical compositions comprising: 1) metronidazole or a pharmaceutically acceptable salt thereof; and magnesium aluminum silicate; or 2) metronidazole or a pharmaceutically acceptable salt thereof; magnesium aluminum silicate; and a flavoring agent. Methods of treating infection utilizing the oral pharmaceutical compositions are also provided.
Public/Granted literature
- US20210069153A1 ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING AN INFECTION USING SAME Public/Granted day:2021-03-11
Information query
